Biocon biologics successfully completes integration of viatris' biosimilar business in 31 countries in europe

Bengaluru, india, nov. 30, 2023 /prnewswire/ -- biocon biologics ltd (bbl), a subsidiary of biocon ltd (bse code: 532523, nse: biocon), today announced that the integration of the viatris' biosimilars business in 31 european countries has been successfully completed. following the acquisition of substantially all of the global biosimilar business of viatris in november 2022 , and the related integration of over 70 emerging market countries in july 2023  and north america in september 2023 , the full transition of viatris' biosimilars operations to biocon biologics ltd in europe represents another significant milestone as a world-leading biosimilars company.
VTRS Ratings Summary
VTRS Quant Ranking